The government has issued a warning about the use of transvaginal surgical meshes to treat pelvic organ prolapse and urinary leakage, noting that thousands of women have reported serious complications including organ perforation, pain, bleeding, infection, and urinary incontinence.
Pelvic organ prolapse affects many women as they age, with the FDA estimating 30 to 50 percent of all women may experience POP during their lifetimes, with 2 percent developing symptoms such as urinary leaking during physical activity. POP occurs when the tissue holding the uterus, bladder, bowel and rectum become stretched or weak and the organs fall down or slip out of place. The mesh is used as a sort of cradle or nest to hold up a patient’s insides.
But over time, erosion or contraction of the mesh – described as being made of a material similar to that of Rubbermaid storage containers — has led to complications, with symptoms including bleeding, severe pelvic pain, painful sexual intercourse and urinary problems.
Transvaginal mesh patch failure
A July 2011 FDA alert warns of serious complications associated with transvaginal mesh patches when implanted to treat pelvic organ prolapse (POP) or stress urinary incontinence (SUI). The FDA has received more than 3,800 reports of adverse effects caused by the surgical mesh or during implantation of the patch.
According to the FDA, significant complications resulting from transvaginal mesh patches are not rare.
Common complications include serious issues such as:
Less frequent problems included:
If you have suffered complications due to the implantation of a transvaginal patch to treat POP, contact the experienced medical device lawyers of McDivitt Law Firm for a free consultation today by calling us toll-free at (877) 846-4878 or click here for a free and confidential evaluation.
Get help at DrugClaim.com
Find answers to your questions
DrugClaim.com, a service of McDivitt Law Firm, provides resources and information to people who might be suffering due to complications from defective prescription drugs and medical devices.